Annual report for Bharat Parenterals Ltd. for FY-2022
28-05-2022
Bharat Parenterals Ltd - 541096 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed herewith the Annual Secretarial Compliance Report of the Company issued by M/s. HDS & Associates, Practicing Company Secretaries of the Company for the financial year ended 31st March, 2022.27-05-2022
Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors For Approval Of Audited Financial Results For The Quarter And Year Ended 31St March, 2022.
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve 1. The Audited financial results of the Company for the Quarter and year ended on March 31, 2022 2. re-appointment of M/s CNK & Associates LLP, Chartered Accountant(FRN 101961W) as Statutory Auditor of the company16-05-2022
Bharat Parenterals Ltd - 541096 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bharat Parenterals Ltd 2 CIN NO. L24231GJ1992PLC018237 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2021-22,2022-23 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-21,2021-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-LUBHANSHI JHALANIDesignation :-COMPANY SECRETARY Name of the Chief Financial Officer :- JIGNESH SHAH Designation : -CFO Date: 09/05/202209-05-2022
Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to the captioned subject, we enclose herewith Reconciliation of Share Capital Audit Report for the quarter ended 31st March, 2022 issued by PCS Niraj Trivedi, Practicing Company Secretary, Vadodara. We request you to kindly take the same on record.21-04-2022
Bharat Parenterals Ltd - 541096 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, For The Year Ended 31St March, 2022
With reference to the captioned subject, we enclose herewith Certificate under Regulation 40(9) of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, for the year ended 31st March, 2022 issued by CS Niraj Trivedi, Practicing Company Secretary, Vadodara. We request you to kindly take the same on record.21-04-2022
Bharat Parenterals Ltd - 541096 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, For The Year Ended 31St March, 2022
With reference to the captioned subject, we enclose herewith Certificate under Regulation 40(9) of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, for the year ended 31st March, 2022 issued by CS Niraj Trivedi, Practicing Company Secretary, Vadodara. We request you to kindly take the same on record.21-04-2022
Bharat Parenterals Ltd - 541096 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayBharat Parenterals Ltd 2CINL24231GJ1992PLC018237 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: LUBHANSHI JHALANI Designation: COMPANY SECRETARY EmailId: cs@bplindia.in Name of the Chief Financial Officer: JIGNESH SHAH Designation: CFO EmailId: account1@bplindia.in Date: 18/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.18-04-2022
Bharat Parenterals Ltd - 541096 - Compliance Certificate For The Period Ended 31St March, 2022
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period October 01, 2021 to March 31, 2022 (both days inclusive) by the Company''s Registrar and Share Transfer Agent,viz., Adroit Corporate Services Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000002227.15-04-2022
Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are forwarding herewith the Confirmation Certificate pursuant to provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 duly sent and confirmed by Adroit Corporate Services Private Limited viz., Company's Registrar and Share Transfer Agent, registered with Securities and Exchange Board of India for the period ended on 31st March, 2022. We request you to kindly take the same on record.15-04-2022